Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT04650126
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Atrosimab (ATM001) in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 12, 2021
Completion: Mar 24, 2022